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Abstract. Several diseases of parkinsonian syndromes present similar
symptoms at early stage and no objective widely used diagnostic meth-
ods have been approved until now. Positron emission tomography (PET)
with 18F-FDG was shown to be able to assess early neuronal dysfunction
of synucleinopathies and tauopathies. Tensor factorization (TF) based
approaches have been applied to identify characteristic metabolic pat-
terns for differential diagnosis. However, these conventional dimension-
reduction strategies assume linear or multi-linear relationships inside
data, and are therefore insufficient to distinguish nonlinear metabolic
differences between various parkinsonian syndromes. In this paper, we
propose a Deep Projection Neural Network (DPNN) to identify charac-
teristic metabolic pattern for early differential diagnosis of parkinsonian
syndromes. We draw our inspiration from the existing TF methods. The
network consists of a (i) compression part: which uses a deep network to
learn optimal 2D projections of 3D scans, and a (ii) classification part:
which maps the 2D projections to labels. The compression part can be
pre-trained using surplus unlabelled datasets. Also, as the classification
part operates on these 2D projections, it can be trained end-to-end effec-
tively with limited labelled data, in contrast to 3D approaches. We show
that DPNN is more effective in comparison to existing state-of-the-art
and plausible baselines.
1 Introduction
Approximately 7 to 10 million people worldwide are suffering from Parkinson’s
disease (PD). On the other hand, very similar clinical signs can appear in pa-
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tients with atypical parkinsonian syndromes, such as multiple system atrophy
(MSA) and progressive supranuclear palsy (PSP) and these conditions account
for approximately 25-30% of all cases of parkinsonian syndromes [1]. Diagno-
sis of parkinsonian patients based on longitudinal clinical follow up remains
problematic with a large number of misdiagnoses in early stage [2]. Thus, early
differential diagnosis is essential for determining adequate treatment strategies
and for achieving the best possible outcome for these patients [3].
Positron emission tomography (PET) captures neuronal dysfunction of PD
using specific in-vivo biomarkers [4,5,6,7,8] and has been shown to be more
advantageous in early diagnosis, far before structural damages to the brain
tissue occurs [7,9,10,11]. Automated approaches such as Principal component
analysis (PCA) has been successfully applied on 18F-FDG PET to extract PD-
related pattern (PDRP), MSA-related pattern (MSARP), and PSP-related pat-
tern (PSPRP) [12,13]. These patterns have been found as effective surrogates to
discriminate between classical PD, atypical parkinsonian syndromes and healthy
control subjects [13]. To account for heterogeneous physiology and enable indi-
vidual pattern visualization, a tensor-factorization based method was developed
by projecting the 3D data into 2D planes containing the discriminative informa-
tion [3]. However, these conventional dimension-reduction based methods assume
linear or multi-linear relationship inside data. In contrast, different subtypes of
parkinsonian syndromes, caused by different protein aggregation (α-synuclein
or Tau), show a non-linear relationship to the anatomical changes. Thus differ-
ence of metabolic patterns between PD, MSA and PSP can be nonlinear due to
these diverse pathological manifestations and heterogeneous propagation among
complex brain connectomes. Therefore, either PCA or tensor factorization is
insufficient to identify nonlinear metabolic differences of various parkinsonian
syndromes, and is susceptible to providing sub-optimal solutions.
Deep learning based approaches have recently been shown to be very effective
in discovering non-linear characteristic patterns within data in an end-to-end
fashion [14,15]. It has been shown to surpass human performance in different
complicated tasks, like image classification. It has also gained a lot of popularity
in the bio-medical community [16] for computerized diagnosis on medical imag-
ing, such as differential diagnosis [15,17,18]. Inspired by these recent successes,
we use a deep learning based architecture for early diagnosis of parkinsonism.
One of the major challenge associated with this task is that our input data
is 3D in nature, with limited amount of labelled training samples. Standard ap-
proaches of going for 3D based CNN models (very high number of learnable
parameters) are prone to overfitting when trained on limited samples. To cir-
cumvent this issue, we draw inspiration from the existing approaches which uses
Tensor Factorization (TF) to project the 3D scans to 2D, and use them for diag-
nosis. Towards this end, we propose a deep projection neural network (DPNN),
which has two parts, (i) Compression Part and (ii) Classification Part. The Com-
pression Part basically mimics TF projection from 3D to 2D. This part can be
pre-trained on a large amount of unlabelled dataset, which is easily available.
This pre-trained model is added to the 2D-CNN based Classification part (lower
model complexity), which is trained end-to-end with limited annotated data.
Although in this paper, we present its application for PET scans, the concept is
fairly generic and can be easily extended to any 3D data.
2 Materials & Methods
2.1 Data Preparation & Preprocessing
A cohort of 257 patients (Dataset-1) with clinically suspected parkinsonian fea-
tures were included in this study. The patients were referred for 18F-FDG PET
imaging and then assessed by blinded movement disorders specialists for more
than 2 years. Finally 136 of them were diagnosed with PD, 91 with MSA and 30
with PSP. All the 3D PET volumes were preprocessed using intensity-normalized
by global mean and spatially normalized to Montreal Neurological Institute
(MNI) space using SPM81 according to a standard PET processing procedure [3].
For optimizing deep networks, the limited availability of PET images of patients
at early stage of parkinsonism could be a bottleneck. Therefore, a database of
1077 subjects (Dataset-2) with 41 various non-parkinsonian neurological diseases
with brain FDG PET images is further included to enhance the data pool.
2.2 DPNN Architecture
We draw our inspiration from prior work which estimated tensor factorized pro-
jection of 3D PET scans and processed them for classification task. In this regard,
we formulated to solve the problem in two parts: (i) Learn a separate network to
mimic the tensor factorization from 3D data, i.e. learning to compress the data
(Compression Part), and (ii) Learn a 2D CNN model to map the compressed
input to one of the classes (Classification Part). A detailed description of both
the parts are provided below with the architectural design in Fig. 1.
Compression Part: Given a 3D PET scan IP ∈ RH×W×D, here we estimate
a function fp(·) which compresses the data to a 2D projection map Pt, so that
fp : IP → Pt, where Pt ∈ RH×W . This non-linear function fp(·) is approximated
by a series of blocks consisting of a 3×3 convolutional layer, batch normalization
and a ReLU activation function. A set of 5 such blocks are stacked together,
which compresses IP sequentially to Pt. The final block uses a sigmoidal non-
linearity instead of ReLU to rescale the activations between [0, 1].
Classification Part: This part takes Pt, the compressed projection map as
input. It learns a mapping fc(·), which maps Pt to the one of the class labels
y. The first 5 blocks consist of a 3 × 3 convolutional layer, batch norm, ReLU
activation and a max pooling layer, reducing the spatial dimensions by a factor
of 2 at every step. The final block consists of a global average pooling instead of
max pooling, squeezing the feature map along spatial dimensions.This is followed
by a 1×1 convolutional layer, softmax layer to project the learnt features to the
1 Statistical Parametric Mapping, http://www.fil.ion.ucl.ac.uk/spm/software/
spm8/, 2009
Fig. 1. Illustration of the overall model architecture of deep projection neural network
(DPNN). All the architectural details regarding the network are shown here.
label probalility space R3, from where y is estimated as the class with highest
probability. More details regarding the size of intermediate feature maps and
stride are indicated in Fig. 1.
2.3 Training Procedure
To tackle the issue of learning such a highly complex model with limited training
data, we propose to address the training procedure in two stages: (i) We lever-
age unlabelled PET data corpus to pre-train the Compression Part, (ii) limited
labelled data is used to learn the weights of the Classification Part, with the
Compression Part initialized to the pre-trained weights.
Pretraining: In this part, we use the unlabelled Dataset-2 {Ii} for pre-training.
We compute the tensor factorized 2D maps of all the volumes as {Gi}. In this
stage, we train the compression part fp(·), using this dataset, with the goal of
mimicking {Gi} as the output of the network. We hypothesize that this provides
a strong initialization to the network for the classification stage. The network
is learnt by jointly optimizing a combination of Mean Square Error (MSE) and
Structural Similarity Index (SSIM) between the target and prediction, defined
as,
L = 1
2Np
∑
r
(P(r)− G(r))2︸ ︷︷ ︸
MSE
− 1
Nw
∑
w
SSIM(wp,wg),︸ ︷︷ ︸
SSIM Index
(1)
SSIM(wp,wg) =
(2µpµg + C1)(2σpg + C2)
(µ2p + µ
2
g + C1)(σ
2
p + σ
2
g + C2)
, (2)
where, P, G, r and Nr are the predicted map, target projection map, pixel-
position, and the total number of pixels respectively. wp and wg represent a
local 6 × 6 window in P and G, and Nw is the total number of such windows.
SSIM is calculated on all the Nw windows and their average value is used in
the cost function. µp, σ
2
p, and σpg are the mean of wp, the variance of wp,
and the covariance of wp and wg, respectively. C1 and C2 are set to ∼ 10−4 and
∼ 9×10−4, respectively. We use SSIM based loss function to preserve the quality
of the predicted map similar to actual Tensor Factorized map. The weights of
the convolutional kernels are initialized using Xavier initialization and Adam
optimizer with a learning rate of 10−4 is used for the weight updates. The β1, β2
and  parameters of the optimizer are set to 0.9, 0.999, and 10−8, respectively.
The training is continued until the validation-cost saturates.
Fine-Tuning: In this stage, the pre-trained compression network is combined
with the classification part, and the weights of the classification part are initial-
ized using Xavier initialization. The whole network is trained in an end-to-end
fashion, minimizing 3-class Cross-Entropy loss function using Adam optimizer
with β1, β2 and  set to 0.9, 0.999, and 10
−8, respectively. The learning rate used
for the classification part is 10−4, while for the compression part it is kept 10−5.
The learning rate of the compression part is kept one order low to prevent high
perturbation in those layer. The weights are regularized with a decay constant
of 10−5, preventing over-fitting. A mini-batch of 10 PET scans are used. The
training is continued until the convergence of the validation loss.
3 Experiments and Results
Experiments: We evaluate our proposed DPNN model by a 5-fold cross-
validation experiment on Dataset-1. An equal distribution of each of samples
from the three classes were ensured in each of the folds. For evaluation, we
used the standard metrics, (i) True Positive Rate (TPR), (ii) True Negative
Rate (TNR), (iii) Positive Predictive Value (PPV), and (iv) Negative Predictive
Value (NPV), consistent with [3].
Baselines: We compare our proposed method against state-of-the-art method
which uses Tensor Factorization (TF), followed by SVM for classification [3].
Apart from this, we define two other baselines to substantiate our claims:
1. BL-1: DPNN, with pre-training using only MSE, to observe the effect of
including SSIM in the cost function.
2. BL-2: DPNN, without pre-training, trained end-to-end, to observe the effect
of pre-training.
For all the experiments we used five-folded cross-validation for evaluation. All
the networks were trained on NVIDIA Titan-Xp GPU with 12GB RAM.
Fig. 2. Projection of 3D PET Volumes generated by the Compression Part of the fine-
tuned DPNN. We can visually observe the distinct patterns exhibited by the three
sub-types MSA, PSP and PD, which not only aids clinicians for inference, but also
aids the Classification part in automated decision making.
Results: Tab. 1 reports the results of our proposed model (DPNN), with defined
baselines and state-of-the-art method, in terms of the mentioned evaluation met-
rics. Comparing with state-of-the-art [3], DPNN outperforms it in most of the
evaluation scores (8 out of 12). Comparing with BL-1, DPNN outperforms it.
This substantiates our previous hypothesis that MSE+SSIM based pre-training
is more effective in providing stronger initialization than MSE alone, which fails
to capture the quality based features in the compression stage. It can be at-
tributed to the fact that SSIM applies stricter constraint on similarity which
forces the network to learn better representations. Also, comparing to BL-2,
we prove our previous claim that pre-training is necessary when training such a
complicated model with limited annotated data. It has improved the specificities
of MSA by 0.79%, PSP by 17.97% and PD by 14.37%, which can play a critical
role for differential diagnosis. It is worth noting that DPNN shows consistent
good performance across all the metrics for the PD class which has the highest
number of samples (viz. 136). While all the models show greatest inconsistency in
the scores for PSP class, which has just 30 representative samples in the dataset.
This is indicative of the fact that given enough data the performance of DPNN
can be increased to an ideal level.
Next, we take a closer look at the learnt Projection Maps in Fig. 2, which
shows example pattern images of MSA, PSP and PD. Patterns similar to tensor-
factorization have been observed in the DPNN Projection results, for example,
visible cerebellum and striatum activities in PD, vanishing cerebellum and stria-
tum activities in MSA and decreasing striatum activity and visible cerebellum
activity in PSP [3]. This confirms that DPNN is capable of extracting physio-
logically meaningful patterns, and use it for final decision making.
Table 1. Classification results of our proposed DPNN, in comparison to comparative
methods and Baselines.
Model
Metrics
MSA PSP PD
TPR TNR PPV NPV TPR TNR PPV NPV TPR TNR PPV NPV
DPNN 84.56 94.58 89.63 91.83 90.00 96.93 79.29 98.67 94.87 93.33 94.28 94.24
BL-1 76.78 93.98 89.83 88.52 86.67 96.04 76.9 98.24 92.65 86.67 89.44 91.57
BL-2 75.67 93.40 87.90 87.97 80.00 96.48 79.25 97.40 91.96 83.33 86.87 90.46
TF+SVM [3] 86.35 93.79 92.85 88.86 97.87 78.96 97.30 85.07 92.44 78.96 89.14 85.73
4 Conclusion
We developed a deep learning method to extract characteristic metabolic pat-
tern for differential diagnosis of parkinsonian syndrome. In contrast to linear or
multi-linear data-reduction methods of the state-of-the-art, the proposed DPNN,
processes 3D-data using 2D-convolutions, can explore the non-linear metabolic
differences between the subtypes. Furthermore, we introduced a training pro-
cedure based on the optimization of SSIM along with MSE which leverages
tensor-factorized maps of inputs, from a domain similar to the task-input do-
main, to overcome the difficulties posed by a small dataset. With limited amount
of data, the novel method has already achieved superior accuracy compared to
the state-of-the-art. The advanced pre-training strategies play a critical role in
the success of this novel method, which prevent the abort of cutting-edge de-
velopments before approaching to a large data-bank. The positive performance
of deep learning in this study encourages a multi-center study, which is actively
in preparation. Although the DPNN patterns extracted in this proof-of-concept
study look similar to the previous tensor factorization, an extensive inspection
by clinicians may discover the characteristic difference matching to improve ac-
curacy. With the increase of data access, the ability of the deep learning methods
to discover new discriminative features will be enhanced, which may provide the
potential for a diagnosis at even earlier stage before motor impairment appears,
i.e. at prodromal parkinsonian stage such as rapid eye movement (REM) sleep
behavior disorder (RBD).
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